| Size | Price | Stock |
|---|---|---|
| 100mg | $39 | In-stock |
| 250mg | $87 | In-stock |
| 1g | $334 | In-stock |
| 5g | $1663 | In-stock |
| 10 g | Get quote | |
| 50 g | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-Y1094 |
| M.Wt: | 493.08 |
| Formula: | C16H24Cl2Rh2 |
| Purity: | >98 % |
| Solubility: | DMSO : 50 mg/mL (ultrasonic) |
[Rh(cod)Cl]2 (Chloro (1,5-cyclooctadiene) rhodium (I) dimer) is an organometallic rhodium (I) dimer precursor and platelet aggregation inhibitor. [Rh(cod)Cl]2 inhibits PAF-induced aggregation in washed rabbit platelets. [Rh(cod)Cl]2 inhibits aggregation induced by PAF, Thrombin, ADP and Collagen in human platelet-rich plasma. [Rh(cod)Cl]2 acts as a catalyst precursor for the hydrogenation of aromatic hydrocarbons, phenols, olefins and BINOL derivatives. [Rh(cod)Cl]2 is used in the research of cardiovascular diseases such as thromboinflammation-related disorders, tumor metastasis and atherosclerosis[1][2].
In Vitro:[Rh(cod)Cl]2 inhibits washed rabbit platelet aggregation induced by platelet-activating factor (PAF), with an IC50 of 5.2 μM[1].
[Rh(cod)Cl]2 inhibits PAF-induced aggregation of human platelet-rich plasma, with an IC50 of 43.3 μM[1].
[Rh(cod)Cl]2 inhibits thrombin (HY-114164)-induced aggregation of human platelet-rich plasma with an IC50 of 16.7 μM[1].
[Rh(cod)Cl]2 inhibits ADP (HY-W010918)-induced aggregation of human platelet-rich plasma with an IC50 of 162 μM[1].
[Rh(cod)Cl]2 inhibits collagen (HY-NP003)-induced aggregation of human platelet-rich plasma, with an IC50 of 69.8 μM[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.